NRC Fundamental Analysis - NATIONAL RESEARCH CORP

Fundamental Rating

Overall NRC gets a fundamental rating of 4 out of 10. We evaluated NRC against 103 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are some minor concerns on its financial health. NRC is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

NRC had positive earnings in the past year.

NRC had a positive operating cash flow in the past year.

Each year in the past 5 years NRC has been profitable.

In the past 5 years NRC always reported a positive cash flow from operatings.

1.2 Ratios

NRC has a Return On Assets of 17.91%. This is amongst the best in the industry. NRC outperforms 99.03% of its industry peers.

With an excellent Return On Equity value of 81.59%, NRC belongs to the best of the industry, outperforming 99.03% of the companies in the same industry.

With an excellent Return On Invested Capital value of 26.72%, NRC belongs to the best of the industry, outperforming 95.15% of the companies in the same industry.

NRC had an Average Return On Invested Capital over the past 3 years of 37.15%. This is significantly above the industry average of 9.71%.

The 3 year average ROIC (37.15%) for NRC is well above the current ROIC(26.72%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	17.91%
ROE	81.59%
ROIC	26.72%

ROA(3y)22.78%

ROA(5y)24%

ROE(3y)62.21%

ROE(5y)57.67%

ROIC(3y)37.15%

ROIC(5y)35.26%

1.3 Margins

NRC has a better Profit Margin (17.13%) than 99.03% of its industry peers.

In the last couple of years the Profit Margin of NRC has declined.

Looking at the Operating Margin, with a value of 24.89%, NRC belongs to the top of the industry, outperforming 97.09% of the companies in the same industry.

NRC's Operating Margin has declined in the last couple of years.

NRC has a better Gross Margin (60.27%) than 82.52% of its industry peers.

In the last couple of years the Gross Margin of NRC has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	24.89%
PM (TTM)	17.13%
GM	60.27%

OM growth 3Y-10.18%

OM growth 5Y-5.95%

PM growth 3Y-11.83%

PM growth 5Y-7.25%

GM growth 3Y-2.32%

GM growth 5Y-1.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NRC is creating value.

NRC has less shares outstanding than it did 1 year ago.

NRC has less shares outstanding than it did 5 years ago.

NRC has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.77 indicates that NRC is not in any danger for bankruptcy at the moment.

With a decent Altman-Z score value of 3.77, NRC is doing good in the industry, outperforming 70.87% of the companies in the same industry.

NRC has a debt to FCF ratio of 4.37. This is a neutral value as NRC would need 4.37 years to pay back of all of its debts.

NRC's Debt to FCF ratio of 4.37 is fine compared to the rest of the industry. NRC outperforms 71.84% of its industry peers.

A Debt/Equity ratio of 2.10 is on the high side and indicates that NRC has dependencies on debt financing.

The Debt to Equity ratio of NRC (2.10) is worse than 76.70% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.1
Debt/FCF	4.37
Altman-Z	3.77

ROIC/WACC3.21

WACC8.33%

2.3 Liquidity

A Current Ratio of 0.54 indicates that NRC may have some problems paying its short term obligations.

NRC has a worse Current ratio (0.54) than 90.29% of its industry peers.

A Quick Ratio of 0.54 indicates that NRC may have some problems paying its short term obligations.

NRC has a Quick ratio of 0.54. This is amonst the worse of the industry: NRC underperforms 86.41% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.54
Quick Ratio	0.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.63%.

Measured over the past years, NRC shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.70% on average per year.

Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -4.16% in the last year.

The Revenue has been growing slightly by 2.25% on average over the past years.

EPS 1Y (TTM)-16.63%

EPS 3Y-10.59%

EPS 5Y-3.7%

EPS Q2Q%-5.05%

Revenue 1Y (TTM)-4.16%

Revenue growth 3Y-1.13%

Revenue growth 5Y2.25%

Sales Q2Q%-4.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NRC is valuated correctly with a Price/Earnings ratio of 16.31.

Based on the Price/Earnings ratio, NRC is valued a bit cheaper than the industry average as 76.70% of the companies are valued more expensively.

Compared to an average S&P500 Price/Earnings ratio of 27.15, NRC is valued a bit cheaper.

		Industry Rank	Sector Rank
PE	16.31
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 66.02% of the companies listed in the same industry.

NRC's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	25.63
EV/EBITDA	10.63

4.3 Compensation for Growth

NRC has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NRC has a Yearly Dividend Yield of 2.96%.

NRC's Dividend Yield is rather good when compared to the industry average which is at 2.37. NRC pays more dividend than 95.15% of the companies in the same industry.

NRC's Dividend Yield is a higher than the S&P500 average which is at 2.42.

		Industry Rank	Sector Rank
Dividend Yield	2.96%

5.2 History

The dividend of NRC decreases each year by -17.40%.

NRC has paid a dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)-17.4%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

46.75% of the earnings are spent on dividend by NRC. This is a bit on the high side, but may be sustainable.

The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.

DP46.75%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NATIONAL RESEARCH CORP

NASDAQ:NRC (6/30/2025, 4:03:09 PM)

After market: 16.8 0 (0%)

16.8

+0.13 (+0.78%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)05-06 2025-05-06

Earnings (Next)08-11 2025-08-11

Inst Owners51.11%

Inst Owner Change-3.56%

Ins Owners9.62%

Ins Owner Change10.88%

Market Cap382.87M

Analysts45

Price TargetN/A

Short Float %3.34%

Short Ratio4.45

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.96%

Yearly Dividend0.48

Dividend Growth(5Y)-17.4%

DP46.75%

Div Incr Years0

Div Non Decr Years0

Ex-Date06-27 2025-06-27 (0.12)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	16.31
Fwd PE	N/A
P/S	2.71
P/FCF	25.63
P/OCF	13.1
P/B	12.9
P/tB	N/A
EV/EBITDA	10.63

EPS(TTM)1.03

EY6.13%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.66

FCFY3.9%

OCF(TTM)1.28

OCFY7.64%

SpS6.2

BVpS1.3

TBVpS-1.71

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	17.91%
ROE	81.59%
ROCE	36.11%
ROIC	26.72%
ROICexc	27.4%
ROICexgc	90.7%
OM	24.89%
PM (TTM)	17.13%
GM	60.27%
FCFM	10.57%

ROA(3y)22.78%

ROA(5y)24%

ROE(3y)62.21%

ROE(5y)57.67%

ROIC(3y)37.15%

ROIC(5y)35.26%

ROICexc(3y)44.09%

ROICexc(5y)48.46%

ROICexgc(3y)273.96%

ROICexgc(5y)N/A

ROCE(3y)48.46%

ROCE(5y)46%

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3Y-21.97%

ROICexc growth 5Y-12.09%

OM growth 3Y-10.18%

OM growth 5Y-5.95%

PM growth 3Y-11.83%

PM growth 5Y-7.25%

GM growth 3Y-2.32%

GM growth 5Y-1.11%

F-Score5

Asset Turnover1.05

Health

		Industry Rank	Sector Rank
Debt/Equity	2.1
Debt/FCF	4.37
Debt/EBITDA	1.51
Cap/Depr	233.71%
Cap/Sales	10.12%
Interest Coverage	13.06
Cash Conversion	70.8%
Profit Quality	61.7%
Current Ratio	0.54
Quick Ratio	0.54
Altman-Z	3.77

F-Score5

WACC8.33%

ROIC/WACC3.21

Cap/Depr(3y)236.79%

Cap/Depr(5y)169.97%

Cap/Sales(3y)9.3%

Cap/Sales(5y)6.92%

Profit Quality(3y)77.54%

Profit Quality(5y)88.07%

High Growth Momentum

Growth

EPS 1Y (TTM)-16.63%

EPS 3Y-10.59%

EPS 5Y-3.7%

EPS Q2Q%-5.05%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-4.16%

Revenue growth 3Y-1.13%

Revenue growth 5Y2.25%

Sales Q2Q%-4.98%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-12.46%

EBIT growth 3Y-11.19%

EBIT growth 5Y-3.83%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-40.79%

FCF growth 3Y-22.27%

FCF growth 5Y-11.96%

OCF growth 1Y-18.18%

OCF growth 3Y-9.26%

OCF growth 5Y-3.29%

NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens